Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127633781 | 12763378 | 1 | I | 201503 | 20150410 | 20160920 | 20160920 | EXP | US-JNJFOC-20150411471 | PHARMACYCLICS | 70.00 | YR | E | M | Y | 0.00000 | 20160920 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127633781 | 12763378 | 1 | PS | IBRUTINIB | IBRUTINIB | 1 | Oral | ON DAY 1-14 | N | 205552 | 560 | MG | CAPSULE | QD | |||||
| 127633781 | 12763378 | 2 | SS | DEXAMETHASONE. | DEXAMETHASONE | 1 | Oral | DAY 1-5 | 0 | 10 | MG/M**2 | TABLET | BID | ||||||
| 127633781 | 12763378 | 3 | SS | CYTARABINE. | CYTARABINE | 1 | Intravenous (not otherwise specified) | 70 MG, CYCLE 2-6, DAY 1 AND 6, IT OR ICV | 0 | 70 | MG | INTRAVENOUS INFUSION | |||||||
| 127633781 | 12763378 | 4 | SS | ETOPOSIDE. | ETOPOSIDE | 1 | Intravenous (not otherwise specified) | OVER 30-60 MINUTES, ON DAY 2-5 | 0 | 50 | MG/M**2 | INTRAVENOUS INFUSION | |||||||
| 127633781 | 12763378 | 5 | SS | DOXORUBICIN | DOXORUBICIN | 1 | Intravenous (not otherwise specified) | OVER 1 HOUR, DAY 2 | 0 | 50 | MG/M**2 | INTRAVENOUS INFUSION | |||||||
| 127633781 | 12763378 | 6 | SS | RITUXIMAB | RITUXIMAB | 1 | Intravenous (not otherwise specified) | ON DAY 1-2 | 0 | 375 | MG/M**2 | INTRAVENOUS INFUSION | |||||||
| 127633781 | 12763378 | 7 | SS | PEGFILGRASTIM | PEGFILGRASTIM | 1 | Subcutaneous | ON DAY 6 | 0 | 6 | MG | ||||||||
| 127633781 | 12763378 | 8 | SS | TEMOZOLOMIDE. | TEMOZOLOMIDE | 1 | Intravenous (not otherwise specified) | 0 | 100 | MG/M**2 | INTRAVENOUS INFUSION |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127633781 | 12763378 | 1 | Central nervous system lymphoma |
| 127633781 | 12763378 | 2 | Central nervous system lymphoma |
| 127633781 | 12763378 | 3 | Central nervous system lymphoma |
| 127633781 | 12763378 | 4 | Central nervous system lymphoma |
| 127633781 | 12763378 | 5 | Central nervous system lymphoma |
| 127633781 | 12763378 | 6 | Central nervous system lymphoma |
| 127633781 | 12763378 | 7 | Central nervous system lymphoma |
| 127633781 | 12763378 | 8 | Central nervous system lymphoma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127633781 | 12763378 | LT |
| 127633781 | 12763378 | DE |
| 127633781 | 12763378 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127633781 | 12763378 | Coma | |
| 127633781 | 12763378 | Diarrhoea | |
| 127633781 | 12763378 | Lung infection | |
| 127633781 | 12763378 | Respiratory failure | |
| 127633781 | 12763378 | Sepsis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127633781 | 12763378 | 1 | 20141015 | 0 | ||
| 127633781 | 12763378 | 2 | 20141015 | 0 | ||
| 127633781 | 12763378 | 4 | 20141016 | 0 | ||
| 127633781 | 12763378 | 5 | 20141016 | 0 | ||
| 127633781 | 12763378 | 6 | 20141015 | 0 | ||
| 127633781 | 12763378 | 7 | 20141016 | 0 | ||
| 127633781 | 12763378 | 8 | 20141016 | 0 |